Is is possible we just don't have any really bankable catalysts...

Is is possible we just don't have any really bankable catalysts for the next few years outside a T/O? By bankable I mean the ones that will get the market excited that we're near another inflexion point for NEU. Daybue is more or less known and milestone payments are a timing issue. A meeting with the FDA and new P2 indications are influential and somewhat material, but what the market really rates is P3 success/FDA acceptance and that is a question of years not months..? As a group on HC, we are in the weeds of this co and ride every announcement, but perhaps the market is taking a 40,000ft view here that not much is going to change for a few years now which is a long, long time in market language. Just my 2 cents!